Accuracy of Noninvasive Diagnostic Tests for the Detection of Significant and Advanced Fibrosis Stages in Nonalcoholic Fatty Liver Disease: A Systematic Literature Review of the US Studies.
Autor: | Gosalia D; Department of Commercial Strategy and Operations, Glympse Bio, Cambridge, MA 02140, USA., Ratziu V; Department of Medicine, Medicine Sorbonne University, 75013 Paris, France., Stanicic F; Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc., Mississauga, ON L5A 2X7, Canada., Vukicevic D; Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc., Mississauga, ON L5A 2X7, Canada., Zah V; Health Economics and Outcomes Research Department, ZRx Outcomes Research Inc., Mississauga, ON L5A 2X7, Canada., Gunn N; Department of Hepatology, Impact Research Institute, Waco, TX 76710, USA., Halegoua-DeMarzio D; Department of Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA., Tran T; Department of Medicine, UCLA Santa Monica Medical Center, Santa Monica, CA 90404, USA.; Department of Medicine, UCLA David Geffen School of Medicine, Los Angeles, CA 90095, USA. |
---|---|
Jazyk: | angličtina |
Zdroj: | Diagnostics (Basel, Switzerland) [Diagnostics (Basel)] 2022 Oct 27; Vol. 12 (11). Date of Electronic Publication: 2022 Oct 27. |
DOI: | 10.3390/diagnostics12112608 |
Abstrakt: | Background: The purpose of this systematic literature review (SLR) was to evaluate the accuracy of noninvasive diagnostic tools in detecting significant or advanced (F2/F3) fibrosis among patients with nonalcoholic fatty liver (NAFL) in the US healthcare context. Methods: The SLR was conducted in PubMed and Web of Science, with an additional hand search of public domains and citations, in line with the PRISMA statement. The study included US-based original research on diagnostic test sensitivity, specificity and accuracy. Results: Twenty studies were included in qualitative evidence synthesis. Imaging techniques with the highest diagnostic accuracy in F2/F3 detection and differentiation were magnetic resonance elastography and vibration-controlled transient elastography. The most promising standard blood biomarkers were NAFLD fibrosis score and FIB-4. The novel diagnostic tools showed good overall accuracy, particularly a score composed of body mass index, GGT, 25-OH-vitamin D, and platelet count. The novel approaches in liver fibrosis detection successfully combine imaging techniques and blood biomarkers. Conclusions: While noninvasive techniques could overcome some limitations of liver biopsy, a tool that would provide a sufficiently sensitive and reliable estimate of changes in fibrosis development and regression is still missing. |
Databáze: | MEDLINE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |